Related Experiment Video
Updated: Jun 10, 2026

Midface Hypoplasia and Cranial Base Morphology in Syndromic Craniosynostosis: A Comparative Analysis Study Using a Predictive Regression Model
Published on: November 4, 2025
Cranial base abnormalities in osteogenesis imperfecta: phenotypic and genotypic determinants.
Moira S Cheung1, Heidi Arponen, Peter Roughley
1Genetics Unit, Shriners Hospital for Children, Montreal, Quebec, Canada.
Osteogenesis imperfecta (OI) patients with lower height Z-scores, indicating more severe disease, have a higher risk of cranial base abnormalities. Bisphosphonate treatment did not show a protective effect against these OI complications.
Area of Science:
- Genetics and Molecular Biology
- Pediatric Endocrinology
- Skeletal Dysplasias
Background:
- Osteogenesis imperfecta (OI) is a rare genetic disorder characterized by bone fragility, often caused by mutations in collagen type I genes.
- Cranial base abnormalities are a significant clinical complication in OI patients, impacting growth and development.
- Understanding the factors contributing to cranial base abnormalities is crucial for managing OI patients.
Purpose of the Study:
- To identify clinical characteristics associated with cranial base abnormalities in patients with osteogenesis imperfecta.
- To investigate the relationship between genotype, clinical severity (height Z-score), and the presence of skull base abnormalities in OI.
- To evaluate the potential protective effect of bisphosphonate treatment on cranial base abnormalities in OI.
Main Methods:
- Cephalometric analysis was performed on 187 OI patients and compared with 191 healthy controls.
- Multivariate logistic regression was used to determine independent predictors of skull base abnormalities, including height Z-score, age, gender, and bisphosphonate treatment history.
- Genotype-phenotype correlations were examined in 140 OI patients with identified mutations in COL1A1 or COL1A2 genes.
Main Results:
- Twenty-two percent of OI patients exhibited at least one abnormal skull base measurement.
- A lower height Z-score was identified as a significant independent predictor of skull base abnormalities in OI patients (OR = 0.53, p < 0.001).
- Bisphosphonate treatment did not demonstrate a protective effect against cranial base abnormalities, even in severely affected patients (height Z-score < -3).
Conclusions:
- Clinical severity of osteogenesis imperfecta, as indicated by height Z-score, is the primary predictor of cranial base abnormalities.
- The type of collagen type I mutation was not independently associated with the prevalence of skull base abnormalities.
- Current findings do not support a protective role for bisphosphonate treatment against the development of cranial base abnormalities in OI.
Related Concept Videos
Bone Formation by Intramembranous Ossification
The process begins when mesenchymal cells in the embryonic skeleton gather together and differentiate into osteogenic cells, which then develop into...
Sutures of the Skull
Sutures are immobile joints between adjacent bones of the skull. The narrow gap between the bones is filled with dense, fibrous connective tissue that unites the bones. The long sutures located between the skull bones are not straight but instead follow irregular, tightly twisting paths. These twisting lines tightly...
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Genetic Lingo
Pleiotropy
Classification of Bones
Long and Short Bones
The appendicular skeleton, particularly the upper and lower limbs, is primarily made of long and short bones. The long...

